Company profile
Kiromic BioPharma Inc.
KRBPQ · OTC Pink (Formerly Nasdaq KRBP; suspended Sept 2023 and moved to OTC Pink. Filed Chapter 7 liquidation 19 Mar 2025 — shares still nominally trade as KRBPQ but the company is being liquidated. [resolved 2026-08-05 by resolve-null-is-public; source: https://www.investing.com/news/sec-filings/kiromic-biopharma-files-for-chapter-7-bankruptcy-93CH-3941959]) · United States
Share price · KRBPQ
Loading chart…
Prices are end-of-day (EOD), delayed by 24 hours · Unadjusted for historical splits · Data via Databento
Assets
(1 total)
| Target & Modality | |||
|---|---|---|---|
| Phase 1 | No discrete molecular targetBiologic — subtype unspecified | Non-Small Cell Lung Cancer |
Upcoming events
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.
Insider transactions
Unlock insider transactions
Research includes SEC Form 4 insider transactions — filed buys, sells, awards and exercises linked to the underlying filings.
Institutional holders
Unlock institutional holders
Research includes quarterly SEC 13F institutional ownership — top holders, aggregate positions and quarter-over-quarter context.